16-84869111-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_031476.4(CRISPLD2):c.914+200A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 152,130 control chromosomes in the GnomAD database, including 11,118 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 11118 hom., cov: 33)
Consequence
CRISPLD2
NM_031476.4 intron
NM_031476.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.258
Publications
9 publications found
Genes affected
CRISPLD2 (HGNC:25248): (cysteine rich secretory protein LCCL domain containing 2) Predicted to enable glycosaminoglycan binding activity. Involved in face morphogenesis. Located in transport vesicle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.639 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CRISPLD2 | ENST00000262424.10 | c.914+200A>G | intron_variant | Intron 8 of 14 | 1 | NM_031476.4 | ENSP00000262424.5 |
Frequencies
GnomAD3 genomes AF: 0.373 AC: 56629AN: 152012Hom.: 11105 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
56629
AN:
152012
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.373 AC: 56679AN: 152130Hom.: 11118 Cov.: 33 AF XY: 0.373 AC XY: 27729AN XY: 74372 show subpopulations
GnomAD4 genome
AF:
AC:
56679
AN:
152130
Hom.:
Cov.:
33
AF XY:
AC XY:
27729
AN XY:
74372
show subpopulations
African (AFR)
AF:
AC:
18990
AN:
41490
American (AMR)
AF:
AC:
4889
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
1090
AN:
3472
East Asian (EAS)
AF:
AC:
3390
AN:
5160
South Asian (SAS)
AF:
AC:
2113
AN:
4830
European-Finnish (FIN)
AF:
AC:
2920
AN:
10586
Middle Eastern (MID)
AF:
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22055
AN:
67976
Other (OTH)
AF:
AC:
839
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1853
3706
5560
7413
9266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
550
1100
1650
2200
2750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1733
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.